A director at Universal Biosensors Inc bought 29,506,606 shares at 0.150AUD and the significance rating of the trade was 84/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two...
Full Article at IIR has reaffirmed its Recommended rating for PIA after undertaking a review post the appointment of a new Portfolio Manager, Harding Loevner. The full report can be found on the IIR website. On 26 July 2021, Pengana International Equities Limited (PIA) announced a fully franked dividend of 1.35 cents per share for the June quarter. This represents an 8% increase on the March quarter dividend and takes the total dividends declared for FY21 of 5.1 cents per share, fully franked....
Announcement of Periodic Review: Moody's announces completion of a periodic review of ratings of Unione di Banche Italiane S.p.A. Global Credit Research- 27 Jan 2021. Paris, January 27, 2021-- Moody's Investors Service has completed a periodic review of the ratings of Unione di Banche Italiane S.p.A. and other ratings that are associated with the same analytical unit.
Rating Action: Moody's upgrades UBI Banca's ratings following acquisition by Intesa Sanpaolo, concluding review. Global Credit Research- 06 Aug 2020. Ratings aligned with those on Intesa Sanpaolo; outlook on senior unsecured debt is negative.
Announcement of Periodic Review: Moody's announces completion of a periodic review of ratings of Unione di Banche Italiane S.p.A. Global Credit Research- 17 Feb 2020. Paris, February 17, 2020-- Moody's Investors Service has completed a periodic review of the ratings of Unione di Banche Italiane S.p.A. and other ratings that are associated with the same analytical unit.
Rating Action: Moody's assigns B2 rating to UBI Banca's €400 million Additional Tier 1 non-viability securities. Global Credit Research- 15 Jan 2020. Paris, January 15, 2020-- Moody's Investors Service today assigned a B2 rating to the E400 million Additional Tier 1 non-viability contingent capital instruments to be issued by Unione di Banche Italiane S.p.A..
Rating Action: Moody's affirms UBI Banca's ratings; outlook on Baa3 senior debt ratings changed to stable. Global Credit Research- 30 Jul 2019. Paris, July 30, 2019-- Moody's Investors Service, today affirmed the ratings and assessments of Unione di Banche Italiane S.p.A..
Summary Universal Biosensors Inc (UBI) is a medical diagnostic company. The company researches, develops and manufactures in vitro diagnostic test devices that are used for professional and consumer point-of-care. The company is working with Siemens Healthcare to develop a range of products for the point-of-care coagulation market and will manufacture test strips for these products. UBI’s major focus areas include coagulation testing, blood glucose testing and other electromechanical cell bas...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.